246 related articles for article (PubMed ID: 31382930)
1. Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China.
Huo F; Lu J; Zong Z; Jing W; Shi J; Ma Y; Dong L; Zhao L; Wang Y; Huang H; Pang Y
BMC Infect Dis; 2019 Aug; 19(1):689. PubMed ID: 31382930
[TBL] [Abstract][Full Text] [Related]
2. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
3. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
4. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
[TBL] [Abstract][Full Text] [Related]
7. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
9. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.
Doustdar F; Khosravi AD; Farnia P; Masjedi MR; Velayati AA
Microb Drug Resist; 2008 Dec; 14(4):273-9. PubMed ID: 19090721
[TBL] [Abstract][Full Text] [Related]
11. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
Lavender C; Globan M; Sievers A; Billman-Jacobe H; Fyfe J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4068-74. PubMed ID: 16189082
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
[TBL] [Abstract][Full Text] [Related]
14. Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.
Rivière E; Whitfield MG; Nelen J; Heupink TH; Van Rie A
Clin Microbiol Infect; 2020 Oct; 26(10):1332-1337. PubMed ID: 32653663
[TBL] [Abstract][Full Text] [Related]
15. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
[TBL] [Abstract][Full Text] [Related]
16. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
Bollela VR; Namburete EI; Feliciano CS; Macheque D; Harrison LH; Caminero JA
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1099-104. PubMed ID: 27393546
[TBL] [Abstract][Full Text] [Related]
17. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
Abe C; Kobayashi I; Mitarai S; Wada M; Kawabe Y; Takashima T; Suzuki K; Sng LH; Wang S; Htay HH; Ogata H
J Clin Microbiol; 2008 Jul; 46(7):2263-8. PubMed ID: 18508939
[TBL] [Abstract][Full Text] [Related]
18. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
Mathuria JP; Nath G; Samaria JK; Anupurba S
Infect Genet Evol; 2009 Dec; 9(6):1352-5. PubMed ID: 19786122
[TBL] [Abstract][Full Text] [Related]
20. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
